Skip to content
★ Sign in to follow
Korea United Pharm Inc. logo

Korea United Pharm Inc. Stock: price and insider trades · South Korea

유나이티드

KR·Mcap ₩255.5BHealth Care

No insider purchase over the last 90 days. The latest, by 강원호, was filed 11 Aug 2026.

Insider Decl.
42
Thresholds
n/a
Buy Volume
€30M
26 ops. · all time
Sell Volume
€23M
5 ops. · all time

Who traded when

BuySale
강덕영4 buys4 sales
김귀자4 buys
강원호2 buys
정원태2 buys
조상민2 buys
김형래1 buy

+2 other insiders

Since the insiders bought

  • Filed 09 Jul 2026 · 123 days ago · €112k
    -4.6%
    Entry ₩17,730 · Close 30 Oct 2026 ₩16,910
  • Filed 08 Jul 2026 · 124 days ago · €28k
    -1.5%
    Entry ₩17,160 · Close 30 Oct 2026 ₩16,910
  • Filed 10 Apr 2026 · 213 days ago · €59k
    -17.5%
    Entry ₩20,500 · Close 30 Oct 2026 ₩16,910

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 631 of 26,913 companies
83.5
score / 100
Value
89
Quality
78
FCF yld10%
Earn yld15%
EV/EBITDA4.3x
ROE12%
Gross mgn56%
Net mgn13%
Debt/EBITDA0.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩16,110
Analyst consensus
1 analysts
2.00/5
₩27,000Target ₩27,000(+68%)₩27,000
Income statement
Revenue₩288.8B
Gross profit₩160.6B56% margin
EBITDA₩61.6B21% margin
Net income₩38.3B12.4% margin
Valuation
PER (forward)6.1x
Beta0.32
Balance sheet & cash
Market cap₩255.5B
Total debt₩14B
Free Cash Flow₩26B
Debt / Equity14%
Profitability & ownership
ROE12.2%
ROA6.8%
% insiders41.7%
% institutions2.9%
Last declaration on 11 August 2026
Declarations43 total
  • ▼
    대표이사Executives(filed)
    €9.0Mest.0DART
    800,000 sharesShareKRXDART:20260811000640
  • Other
    Other(filed)
    0DART
  • ▲
    대표이사Executives(filed)
    €9.0Mest.0DART
    800,000 sharesShareKRXDART:20260811000632
    Canonical exit: 9 Nov 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    상무이사Executives(filed)
    €112kest.0DART
    11,300 sharesShareKRXDART:20260709000468
    Canonical exit: 7 Oct 2026 (T+90)
  • ▲
    Executives
    €80kest.0DART
    8,000 sharesShareKRXDART:20260708000484
    Canonical exit: 29 Sept 2026 (T+90)
  • ▲
    상무이사Executives(filed)
    €28kest.0DART
    2,763 sharesShareKRXDART:20260708000479
    Canonical exit: 6 Oct 2026 (T+90)
  • ▼
    대량보유자Executives
    €420kest.0DART
    42,465 sharesKRXDART:20260602000476
  • ▲
    부사장Executives
    102M KRW16DART
    5,140 shares@ ₩19,853.77430.037% mcap51.6% of flowShareKRXDART:20260410003305
    Canonical exit: 7 Jul 2026 (T+90)
  • ▲
    Executives
    €118kest.0DART
    10,000 sharesKRXDART:20260410003331
    Canonical exit: 9 Jul 2026 (T+90)
  • ▲
    부사장Executives
    97M KRW16DART
    4,860 shares@ ₩19,900.000.035% mcap48.4% of flowShareKRXDART:20260408003155
    Canonical exit: 5 Jul 2026 (T+90)
  • ▼
    Executives
    €11kest.0DART
    1,000 sharesKRXDART:20260402003671
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Executives
    €953kest.0DART
    84,750 sharesKRXDART:20251224000700
    Canonical exit: 23 Mar 2026 (T+90)
  • ▲
    Executives
    €5.1Mest.0DART
    435,000 sharesKRXDART:20251222000436
    Canonical exit: 19 Mar 2026 (T+90)
  • ●
    Executives
    Executives
    0DART
  • ▼
    대표이사Executives(filed)
    €13.7Mest.0DART
    1,200,000 sharesShareKRXDART:20251215000429
  • ▲
    대표이사Executives(filed)
    €13.7Mest.0DART
    1,200,000 sharesShareKRXDART:20251215000436
    Canonical exit: 15 Mar 2026 (T+90)
  • ▲
    부사장Executives(filed)
    €1,683est.0DART
    137 sharesShareKRXDART:20250103000525
    Canonical exit: 3 Apr 2025 (T+90)
  • ▲
    부사장Executives(filed)
    €20kest.0DART
    1,612 sharesShareKRXDART:20241223000411
    Canonical exit: 23 Mar 2025 (T+90)
  • ▲
    상무이사Executives(filed)
    €4,910est.0DART
    400 sharesShareKRXDART:20241219000494
    Canonical exit: 19 Mar 2025 (T+90)
  • ▲
    부사장Executives(filed)
    €28kest.0DART
    2,230 sharesShareKRXDART:20241216000343
    Canonical exit: 16 Mar 2025 (T+90)
  • ▲
    부사장Executives(filed)
    €37kest.0DART
    3,000 sharesShareKRXDART:20241204000294
    Canonical exit: 4 Mar 2025 (T+90)
  • ▲
    부사장Executives(filed)
    €37kest.0DART
    3,000 sharesShareKRXDART:20241204000302
    Canonical exit: 4 Mar 2025 (T+90)

25 of 43 declarations

About Korea United Pharm Inc.

Of the 42 filings at 유나이티드 (Korea United Pharm Inc.), only two have an amount: two purchases by 정원태 (부사장), EUR 59,188 on April 8, 2026 and EUR 55,514 on April 6, 2026, or EUR 114,702. The rest of the record, published from July 14, 2021 to August 11, 2026, can only be counted in filings: 26 purchases and 5 sales, or 84% purchases.

Two executives carry most of it: 강덕영 (대표이사), with 13 filings including 7 purchases and 4 sales, and 김귀자 (부사장), with 10 purchases. 김성겸 (상무이사) files 7, one of them a sale. 강원호, also 대표이사, signs 2 purchases, as does 조상민 (상무이사). From December 4, 2024 to January 3, 2025, 4 distinct filers bought.

Read moreShow less

The South Korean health care company is valued at KRW 277.6 billion, and its 10 filers hold 41.7% of it. The year 2024 has 16 filings and 2026 has 13. Over the last twelve months: 18 filings, of which 10 purchases and 4 sales. Filings appear a median of 1 day after the trade, a very short delay.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations